1/49
Vocabulary flashcards covering basic pharmacology, neurotransmitter pathways, receptor classifications, psychotropic medications, and endocrine systems from Chapters 4 and 5.
Endogenous
Molecules or processes that occur naturally within the body.
Exogenous
Molecules originating from outside the body (such as drugs or toxins) used to alter physiology and behavior.
Receptor Agonist
A ligand that mimics the effects of a neurotransmitter, having high affinity and activating the receptor to produce a biological effect.
Receptor Antagonist
A ligand that binds to a receptor without activating it, blocking active ligands from binding and producing no cellular effect.
Competitive Ligand
A drug or substance that acts as an agonist, antagonist, or inverse agonist by binding directly to the primary transmitter site.
Noncompetitive Ligand (Neuromodulator)
A substance that binds to a separate modulatory site on a receptor rather than the primary transmitter-binding site.
Amino Acid Neurotransmitters
A class of small organic molecules that includes Glutamate, Glycine, and GABA.
Amine Neurotransmitters
A class of small organic molecules that includes Acetylcholine (ACh), Dopamine, Norepinephrine, Serotonin, and Histamine.
Peptide Neurotransmitters
Short amino acid chains stored in and released from secretory granules at the axon terminal, such as Dynorphin, Enkephalins, and Somatostatin.
Criteria for Neurotransmitter Classification
Glutamate
The most prevalent excitatory neurotransmitter in the brain.
GABA
The primary inhibitory neurotransmitter in the central nervous system.
Acetylcholine (ACh) Projection Pathways
Originates in the basal forebrain (septal nucleus, nucleus basalis) and midbrain tegmental nuclei, projecting to the forebrain (hippocampus, limbic system, cerebral cortex) and midbrain/thalamus.
Nigrostriatal (Mesostriatal) Pathway
A dopamine pathway originating in the substantia nigra and projecting to the striatum (caudate nucleus and putamen), primarily involved in motor control.
Mesolimbic Pathway
A dopamine pathway originating in the ventral tegmental area (VTA) and projecting to the nucleus accumbens and amygdala, involved in reward, reinforcement, emotion, and addiction.
Mesocortical Pathway
A dopamine pathway originating in the ventral tegmental area (VTA) and projecting to the prefrontal cortex, involved in short-term memory, planning, strategy, and problem-solving.
Tuberoinfundibular Pathway
A dopamine pathway originating in the hypothalamus and projecting to the pituitary gland, involved in hormonal regulation, maternal behavior, pregnancy, and sensory processes.
Norepinephrine (NE) System
Originates in the locus coeruleus and lateral tegmental area, projecting to the cortex, basal ganglia, hippocampus, hypothalamus, and spinal cord to modulate mood, arousal, sexual behavior, analgesia, and fight-or-flight responses.
Serotonin (5-HT) System
Originates in the raphe nuclei of the brainstem, projecting widely to mediate mood, anxiety, appetite, sleep, and pain/spinal reflexes.
Nicotinic Receptors
Ionotropic, mostly excitatory acetylcholine receptors found at neuromuscular junctions; stimulated by nicotine and blocked by curare.
Muscarinic Receptors
Metabotropic (G protein-coupled) acetylcholine receptors that produce slower excitatory or inhibitory responses and are blocked by atropine and scopolamine.
Ionotropic Glutamate Receptor Subtypes
AMPA (passes Na+, K+), NMDA (passes Na+, K+, Ca2+), and Kainate (passes Na+, K+); all produce excitatory postsynaptic potentials (EPSPs).
GABAA Receptor
A fast, ionotropic chloride (Cl−) channel containing binding sites for GABA, benzodiazepines, barbiturates/alcohol, picrotoxin, and steroids/neurosteroids.
Neuromuscular Junction
A chemical synapse between a motor neuron and a muscle fiber where ACh binding allows Na+ influx, generating an end-plate potential that triggers muscle contraction.
Catecholamines
A group of monoamines sharing a catechol and amine group, consisting of Dopamine, Norepinephrine, and Epinephrine.
Parkinson's Disease
A movement disorder marked by tremors, rigidity, and a shuffling gait, caused by the progressive loss of dopaminergic neurons in the substantia nigra of the nigrostriatal pathway.
Affinity
The degree of chemical attraction or binding strength between a ligand and a receptor.
Efficacy
The capacity of a bound ligand to activate a receptor and trigger an intracellular biological response.
Caffeine
An exogenous neuromodulator that induces arousal by blocking endogenous adenosine receptors, disinhibiting catecholamine release.
Typical Antipsychotics
First-generation neuroleptics that act as selective dopamine D2 receptor antagonists.
Atypical Antipsychotics
Antipsychotics that block dopamine receptors along with specific serotonin receptors, reducing negative symptoms.
Monoamine Oxidase (MAO) Inhibitors
Antidepressants that inhibit the MAO enzyme, preventing the synaptic enzymatic breakdown of monoamine neurotransmitters.
Tricyclic Antidepressants
Antidepressants that elevate synaptic levels of norepinephrine and serotonin by blocking their presynaptic reuptake.
Selective Serotonin Reuptake Inhibitors (SSRIs)
Antidepressants (such as Prozac and Zoloft) that selectively inhibit the reuptake of serotonin into presynaptic terminals.
Endocannabinoids
Endogenous retrograde messengers (e.g., anandamide/AEA and 2-AG) synthesized postsynaptically that travel backward to presynaptic CB1 or CB2 receptors to regulate transmitter release.
Cocaethylene
A psychoactive compound formed in the body when cocaine and alcohol are consumed together, contributing to dual dependence.
Disease Model of Addiction
The view that addiction is characterized by underlying brain alterations requiring medical treatment rather than moral punishment.
Varenicline (Chantix)
An α4β2 partial nicotinic acetylcholine receptor agonist utilized for smoking cessation.
Pineal Gland
An endocrine gland that secretes melatonin to regulate sleep-wake cycles and reproductive/seasonal rhythms.
Posterior Pituitary Hormones
Oxytocin (mediates uterine contractions, milk letdown, and social bonding) and Vasopressin (AVP/ADH; maintains water balance, blood pressure, and inhibits urine formation).
Anterior Pituitary Hormones
Hormones including ACTH, TSH, FSH, LH, Prolactin, and Growth Hormone (GH), which regulate other endocrine glands, growth, metabolism, lactation, and reproduction.
Thyroid Gland
An endocrine gland releasing thyroxine (T3, T4) to regulate metabolism and calcitonin to inhibit bone calcium release.
Parathyroid Glands
Endocrine glands that secrete parathyroid hormone to stimulate the release of calcium from bones.
Adrenal Cortex
The outer 80% of the adrenal gland; secretes glucocorticoids (cortisol) for stress responses and glucose metabolism, and aldosterone for sodium regulation.
Adrenal Medulla
The inner 20% of the adrenal gland; secretes epinephrine and norepinephrine to facilitate the fight-or-flight response and emotional arousal.
Pancreatic Islet Cells
Endocrine cells that release insulin (to lower blood glucose) and glucagon (to elevate blood glucose).
Endocrine vs. Synaptic Communication
Endocrine signaling releases hormones into the bloodstream to reach distributed targets with specific receptors, whereas synaptic signaling transmits neurotransmitters across a narrow synaptic cleft to an adjacent target cell.
Psychosocial Dwarfism
A developmental growth failure resulting from severe early life stress, which suppresses growth factors such as somatomedins.
Goiter
An enlargement of the thyroid gland typically caused by a dietary iodine deficiency.
Hypothalamic-Pituitary-Adrenal (HPA) Axis
A neuroendocrine stress pathway: Stress triggers hypothalamic CRH release, which induces anterior pituitary ACTH secretion, stimulating adrenal cortical cortisol release.